AIM
ABBV icon

Alhambra Investment Management’s AbbVie ABBV Stock Holding History

Alhambra Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$736K Sell
2,924
-285
-9% -$61.3K 0.32% 72
2026
Q1 		$698K Buy
3,209
+42
+1% +$9.32K 0.32% 73
2025
Q4 		$724K Sell
3,167
-461
-13% -$105K 0.34% 67
2025
Q3 		$840K Sell
3,628
-301
-8% -$61.3K 0.4% 62
2025
Q2 		$729K Buy
3,929
+432
+12% +$80.3K 0.36% 67
2025
Q1 		$733K Buy
3,497
+2
+0.1% +$389 0.38% 62
2024
Q4 		$621K Buy
3,495
+360
+11% +$66.2K 0.32% 75
2024
Q3 		$619K Buy
3,135
+4
+0.1% +$747 0.32% 78
2024
Q2 		$537K Buy
3,131
+555
+22% +$91.9K 0.29% 82
2024
Q1 		$469K Sell
2,576
-113
-4% -$19.5K 0.26% 103
2023
Q4 		$417K Sell
2,689
-74
-3% -$10.8K 0.25% 105
2023
Q3 		$412K Sell
2,763
-69
-2% -$10.1K 0.27% 100
2023
Q2 		$382K Sell
2,832
-39
-1% -$5.72K 0.25% 104
2023
Q1 		$458K Buy
2,871
+125
+5% +$19.1K 0.31% 88
2022
Q4 		$444K Sell
2,746
-11
-0.4% -$1.69K 0.32% 89
2022
Q3 		$370K Buy
2,757
+1
+0% +$143 0.28% 98
2022
Q2 		$422K Sell
2,756
-24
-0.9% -$3.67K 0.31% 92
2022
Q1 		$451K Sell
2,780
-835
-23% -$121K 0.3% 97
2021
Q4 		$490K Sell
3,615
-466
-11% -$55K 0.34% 89
2021
Q3 		$440K Hold
4,081
– – 0.34% 93
2021
Q2 		$460K Buy
4,081
+9
+0.2% +$1.01K 0.35% 91
2021
Q1 		$441K Buy
4,072
+238
+6% +$25.5K 0.36% 89
2020
Q4 		$411K Sell
3,834
-39
-1% -$3.75K 0.44% 80
2020
Q3 		$339K Buy
3,873
+984
+34% +$92.6K 0.41% 82
2020
Q2 		$284K Buy
+2,889
New +$254K 0.37% 77

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Alhambra Investment Management's ABBV Position: Q2 2026 in Review

Alhambra Investment Management reduced its AbbVie (ABBV) stake by 8.9% in Q2 2026, selling an estimated $61.3K and leaving 2,924 shares worth $736K. The position accounts for 0.32% of the portfolio, ranked #72.

Alhambra Investment Management first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. The position peaked at $840K in Q3 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Alhambra Investment Management held 2,924 shares of AbbVie worth $736K as of Q2 2026.
  • Alhambra Investment Management sold 285 AbbVie shares in Q2 2026, an estimated $61.3K.
  • AbbVie made up 0.32% of Alhambra Investment Management's portfolio in Q2 2026, its #72 holding.
  • Alhambra Investment Management first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
  • Alhambra Investment Management's AbbVie position peaked at $840K in Q3 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alhambra Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.